CTRI/2022/06/043104尚未招募未知
Prevalence of iron deficiency anemia in cancer patient andtherapeutic outcomes
Dr Malini Mohan0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Hemoglobin level less than or equal to 10 g/dL
- •- Transferrin saturation < 20 %
- •- Any stage solid malignancies
排除标准
- •- Age less than 18yrs
- •- Pregnant women
- •- any evidence of hemolysis
- •- Active gastrointestinal bleeding (stool occult blood positive)
- •- active infection requiring systemic antibiotics
- •- HIV infection
- •- active Tuberculosis infection
- •- liver/ renal dysfunction - Grade 2 or higher based on National Cancer Institute Common Toxicity Criteria: Bilirubin >1.5 times normal, Transaminases >2.5 times normal), renal dysfunction (serum creatinine levels > or equal to 2.0 mg/dL)
- •- Malignant Bone marrow infiltration
- •-Received iron supplementation / blood transfusion in the preceding 4 weeks
研究者
相似试验
招募中
不适用
Iron deficiency anemia in cancer patient: proposal of a new treatmentC15.378.071.196.300Iron Deficiency AnemiaRBR-2vd7nbniversidade Ceuma
已完成
不适用
Prospective Evaluation of Iron Status in Cancer Patients Beginning ChemotherapyCancerNCT01968304Centre Antoine Lacassagne480
进行中（未招募）
1 期
A study to investigate the efficacy and safety of Injectafer® (ferric carboxymaltose injection) in anemia due to cancer and chemotherapycancer- and chemotherapy-related anemiaMedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851EUCTR2016-002021-11-BGuitpold Pharmaceuticals, Inc.222
进行中（未招募）
1 期
A study to investigate the efficacy and safety of Injectafer® (ferric carboxymaltose injection) in anemia due to cancer and chemotherapycancer- and chemotherapy-related anemiaMedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851EUCTR2016-002021-11-PLuitpold Pharmaceuticals, Inc.222
进行中（未招募）
1 期
A study to investigate the efficacy and safety of Injectafer® (ferric carboxymaltose injection) in anemia due to cancer and chemotherapycancer- and chemotherapy-related anemiaMedDRA version: 19.1Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851EUCTR2016-002021-11-HUuitpold Pharmaceuticals, Inc.400